Cervical cancer detection assay, 6/15

June 2015—Enzo Biochem announced the development of the FlowScript assay in detection of messenger RNA from HPV oncogenes E6 and E7. The FlowScript technology platform is a proprietary flow-cytometry-based molecular detection system for the multiplex analysis of cell function and identity; the HPV E6/E7 assay is the first product to use this novel platform. Analysis is performed on a small volume of a liquid cytology specimen and can be incorporated as a reflex test measure following abnormal Pap smear results.

The assay, and the platform on which it is based, allows for the simultaneous analy-sis of several different genes expressed in every cell in a given sample, making it possible to produce clinically relevant data at the single cell level. Additionally, the assay’s use of external control improves run-to-run consistency, reducing hands-on time. The company anticipates applying this platform to, for example, the study of other cancers, immune-related disorders, and drug development.

Enzo Biochem, 212-583-0100